Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_assertion description "[In addition, mammalian target of rapamycin (mTOR), an intracellular serine/threonine kinase, is also implicated in HIF-1a regulation, thus reinforcing the rationale for using mTOR inhibitors (rapamycin) in CCRCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_assertion evidence source_evidence_literature NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_assertion SIO_000772 20437403 NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_assertion wasDerivedFrom befree-2016 NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_assertion wasGeneratedBy ECO_0000203 NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.
- befree-2016 importedOn "2016-02-19" NP809741.RAdX2dIUsPBeacY2uRGkSA4M2uIXtmRXfdShVAIGMfbtM130_provenance.